Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

Thumbnail

Can-do Cath Labs: Improving PCI Outcomes & Efficiency

Improving efficiencies and patient outcomes in the cath lab can go hand in hand. 

Accreditation for Cardiovascular Excellence achieves record-breaking cardiac cath lab applications

Rounding out a very successful year, Accreditation for Cardiovascular Excellence (ACE) reports they have reached record-breaking numbers of accreditation applications for cardiac cath labs in 2013. “Accreditation applications have more than doubled since 2012,” said Mary Heisler, RN, BA, ACE Executive Director. “More labs are realizing the importance of accountable metrics and know it’s time to get started on the quality journey with ACE.”

AccessClosure announces distribution agreement for the FLASH Ostial System

AccessClosure, Inc., the market leader in extravascular closure devices, announced today an exclusive agreement with Ostial Corporation to distribute the Flash Ostial System Dual Balloon Angioplasty Catheter in the United States. The Flash Ostial System is designed to help overcome the challenges of aorto-ostial stenting and compliments the Mynx® Product Family of Vascular Closure Devices to expand AccessClosure’s portfolio.

Quality of life improves dramatically following stenting in patients with peripheral artery disease

Data from a study led by researchers at Saint Luke's Mid America Heart Institute<http://globalmessaging1.prnewswire.com/clickthrough/servlet/clickthrough?msg_id=7563978&adr_order=59&url=aHR0cDovL3d3dy5zYWludGx1a2VzaGVhbHRoc3lzdGVtLm9yZy9zZXJ2aWNlcy9oZWFydC1hbmQt%0AdmFzY3VsYXItY2FyZGlvdmFzY3VsYXItc2VydmljZXM%3D> showed marked, long-term improvement in health status in patients suffering from peripheral artery disease treated with the S.M.A.R.T. Nitinol Self-Expandable Stent. The study was sponsored by Cordis Corporation, (Fremont, Calif.), manufacturer of the S.M.A.R.T. Stent.

Rates of false activation of cath lab rise as D2B times dip

Rates of false activation of a cardiac catheterization laboratory for primary PCI increased from 15 percent in 2007 to 40 percent in 2011 at one facility, an analysis published in the August issue of the American Journal of Managed Care found.

The Accreditation for Cardiovascular Excellence (ACE) publishes new standards for the cardiac cath lab

The Accreditation for Cardiovascular Excellence (ACE) announced this week that updated standards for cardiac intervention procedures have been published and are now available for download on the ACE website. ACE updated its Cath/PCI standards to align with the recently published clinical competency document for PCI which includes information on physician training, clinical competency criteria and the updated expert consensus document published in 2012.

Cath lab alley-oop: 5 slam-dunk ways to cut cost, add value

ATLANTA—Opportunities exist within many cardiovascular programs to trim out costs and add value. But where? Suzette Jaskie, president and CEO of MedAxiom Consulting, offered five “slam dunk” approaches June 13 at the Cardiovascular Service Line Symposium in Atlanta.

Slides: When a cath lab leader says ‘I quit’

Have you ever wondered about the financial consequences of losing your cath lab director? Michael G. Vanderlans, relationship manager in the permanent placement division of Springboard Healthcare, crunched the numbers, including the cost of potential lost revenue, staff turnover and an interim director for six months.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.